Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Clover's earnings before interest and taxes (EBIT) for the
six
months ended in Jan. 2026 was A$6.13 Mil.
Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jan. 2026 was A$13.24 Mil.
EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Clover's annualizedROC % for the quarter that ended in Jan. 2026 was 12.44%.
Clover's annualizedROC (Joel Greenblatt) % for the quarter that ended in Jan. 2026 was 24.72%.
EBIT is also linked to Joel Greenblatt's definition of earnings yield.
Clover's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2026 was 10.02%.
Clover (ASX:CLV) EBIT Explanation
1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Clover's annualizedROC % for the quarter that ended in Jan. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clover EBIT Related Terms
Clover EBIT Historical Data
* Premium members only.
The historical data trend for Clover's EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Clover's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clover EV-to-EBIT vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Clover's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Clover's EV-to-EBIT falls into.
EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.
EBIT for the trailing twelve months (TTM) ended in Jan. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$13.24 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clover (ASX:CLV) has a EBIT of A$13.24 Mil as of Jan. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Clover.
Is Clover's EBIT too high?
Clover's current EBIT is A$13.24 Mil. Overall, Clover has a GF Score™ of 65/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clover's EBIT compare to KHC and GIS?
Clover's EBIT of A$13.24 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Consumer Packaged Goods company?
A good EBIT depends on the Consumer Packaged Goods industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Clover. Clover's current EBIT is A$13.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clover stock overvalued right now?
Based on GuruFocus' analysis, Clover (ASX:CLV) is currently considered Modestly Overvalued. The stock's GF Value™ is A$0.76, compared to a current price of A$0.85 — trading 11.8% above its estimated fair value. The current EBIT is A$13.24 Mil. Clover's overall GF Score™ is 65/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Clover (ASX:CLV), the current EBIT is A$13.24 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clover (ASX:CLV) Overvalued in 2026?
Based on GuruFocus' analysis, Clover stock appears to be overvalued.
The current stock price of A$0.85 is trading 11.8% above its estimated GF Value™ of A$0.76.
GuruFocus considers Clover to be Modestly Overvalued.
Key valuation signals for ASX:CLV:
EBIT: A$13.24 Mil
GF Value™: A$0.76 vs. price of A$0.85 (11.8% above fair value)
No single metric tells the full story. See the ASX:CLV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clover Corp Ltd provides nutritional and functional ingredients. The company is involved in the production of encapsulated powders, and research and product development of functional food and infant nutrition ingredients. It offers Nu-Mega Hi docosahexaenoic acid tuna oils for use in infant formula and pharmaceutical products; and Ocean Gold refined tuna oils. Its products include DHA oils, DHA powders, and Microencapsulation. Geographically, the group has a business presence in Australia, New Zealand, Asia, Europe and the Americas. Majority of the revenue is derived from Australia/New Zealand.
65GF Score
Get the complete analysis for ASX:CLV
EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CLV has been successfully added to your 
